Literature DB >> 15837792

Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression.

Huabao Xiong1, Hongxing Li, Hee Jeong Kong, Yibang Chen, Jie Zhao, Sidong Xiong, Bo Huang, Hua Gu, Lloyd Mayer, Keiko Ozato, Jay C Unkeless.   

Abstract

Interferon regulatory factor (IRF)-8/interferon consensus sequence-binding protein is regulated by both transcription and degradation. IRF-8 induced in peritoneal macrophages by interferon-gamma and lipopolysaccharide was degraded rapidly, and degradation of IRF-8 was blocked by MG132, the proteasome inhibitor, but inhibitors of calpain and lysosomal enzymes had no effect. The ubiquitination of IRF-8 was shown by co-immunoprecipitation from RAW264.7 macrophages retrovirally transduced with IRF-8 and hemagglutinin-ubiquitin. The dominant negative ubiquitin mutants K48R and K29R inhibited IRF-8 degradation in 293T cells, confirming the relationship between ubiquitination of IRF-8 and its degradation. IRF-8 carboxyl-terminal truncation mutants were not ubiquitinated and were consequently stable, indicating that the carboxyl-terminal domain of IRF-8 controls ubiquitination. The ubiquitin-protein isopeptide ligase (E3) that ubiquitinated IRF-8 was likely to be Cbl, which formed a complex with IRF-8, demonstrable by both immunoprecipitation and gel filtration. Furthermore, IRF-8 stability was increased by dominant negative Cbl, and IRF-8 ubiquitination was significantly attenuated in Cbl-/- cells. Reflecting increased stability and expression, the IRF-8 carboxyl-terminal deletion mutant induced interleukin (IL)-12 p40 promoter activity much more strongly than IRF-8 did. Furthermore, IRF-8-induced IL-12 p40 synthesis in RAW264.7 cells was enhanced by dominant negative Cbl, and peritoneal macrophages from Cbl-/- mice showed increased IL-12 p40 protein production. Taken together, these results suggest that the proteasomal degradation of IRF-8 mediated by the ubiquitin E3 ligase Cbl down-regulates IL-12 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837792     DOI: 10.1074/jbc.M414296200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

Review 2.  IRF8 regulates myeloid and B lymphoid lineage diversification.

Authors:  Hongsheng Wang; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis.

Authors:  Manikuntala Kundu; Sushil Kumar Pathak; Kuldeep Kumawat; Sanchita Basu; Gargi Chatterjee; Shresh Pathak; Takuya Noguchi; Kohsuke Takeda; Hidenori Ichijo; Christine B F Thien; Wallace Y Langdon; Joyoti Basu
Journal:  Nat Immunol       Date:  2009-07-13       Impact factor: 25.606

Review 4.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 5.  Molecular mechanisms of regulation of Toll-like receptor signaling.

Authors:  Cynthia A Leifer; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2016-06-24       Impact factor: 4.962

6.  Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner.

Authors:  Caleb M Bailey; Daniel E Abbott; Naira V Margaryan; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

7.  IFN regulatory factor 8 regulates MDM2 in germinal center B cells.

Authors:  Jeff X Zhou; Chang Hoon Lee; Chen Feng Qi; Hongsheng Wang; Zohreh Naghashfar; Sadia Abbasi; Herbert C Morse
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

8.  The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity.

Authors:  Ji Young Kim; Keiko Ozato
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.

Authors:  Kai-Li He; Arunkumar B Deora; Huabao Xiong; Qi Ling; Babette B Weksler; Ruben Niesvizky; Katherine A Hajjar
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

10.  IRF6 in development and disease: a mediator of quiescence and differentiation.

Authors:  Caleb M Bailey; Mary J C Hendrix
Journal:  Cell Cycle       Date:  2008-04-29       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.